Erica J. Melief, Ph.D.

Affiliations: 
University of Washington, Seattle, Seattle, WA 
Area:
Opioid receptors, potassium channels
Google:
"Erica Melief"
Mean distance: 15.08 (cluster 40)
 
SNBCP

Parents

Sign in to add mentor
Charles Chavkin grad student 2011 University of Washington
 (C-Jun N-Terminal Kinase Activation Disrupts Opioid Receptor Signaling.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Melief EJ, McKinley JW, Lam JY, et al. (2018) Loss of glutamate signaling from the thalamus to dorsal striatum impairs motor function and slows the execution of learned behaviors. Npj Parkinson's Disease. 4: 23
Melief EJ, Gibbs JT, Li X, et al. (2016) Characterization of cognitive impairments and neurotransmitter changes in a novel transgenic mouse lacking Slc10a4. Neuroscience
Garrett Morgan R, Gibbs JT, Melief EJ, et al. (2015) Relative contributions of severe dopaminergic neuron ablation and dopamine depletion to cognitive impairment. Experimental Neurology. 271: 205-214
Kuhar JR, Bedini A, Melief EJ, et al. (2015) Mu opioid receptor stimulation activates c-Jun N-terminal kinase 2 by distinct arrestin-dependent and independent mechanisms. Cellular Signalling. 27: 1799-806
Melief EJ, Cudaback E, Jorstad NL, et al. (2015) Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of Alzheimer's disease. Journal of Neuroscience Research. 93: 1413-22
Li X, Melief E, Postupna N, et al. (2015) Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosis. The American Journal of Pathology. 185: 230-9
Yang Y, Cudaback E, Jorstad NL, et al. (2013) APOE3, but not APOE4, bone marrow transplantation mitigates behavioral and pathological changes in a mouse model of Alzheimer disease. The American Journal of Pathology. 183: 905-17
Melief EJ, Miyatake M, Carroll FI, et al. (2011) Duration of action of a broad range of selective κ-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation. Molecular Pharmacology. 80: 920-9
Melief EJ, Miyatake M, Bruchas MR, et al. (2010) Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling. Proceedings of the National Academy of Sciences of the United States of America. 107: 11608-13
Land BB, Bruchas MR, Lemos JC, et al. (2008) The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 407-14
See more...